{"title":"过氧化物还氧蛋白6:细胞衰老和年龄相关疾病的调控靶点","authors":"Hao Wang, Yingjie Zhao, Fuli Zhou, Fan Chen, Tianyu Chen, Jinhong Wang, Hao Liu, Cheng Sun, Renpeng Zhou, Wei Hu, Chao Lu","doi":"10.1089/ars.2024.0793","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Significance:</i></b> Oxidative stress is a key factor in inducing cellular senescence and age-related diseases. When the redox balance within the body is disrupted, sustained oxidative stress can lead to cellular senescence. The accumulation of senescent cells, in turn, triggers a variety of age-related diseases. Peroxiredoxin 6 (Prdx6) is a critical target in the intracellular regulation of redox homeostasis. <b><i>Recent Advances:</i></b> Prdx6 is a widely expressed antioxidant enzyme and the sole member of the peroxiredoxin family endowed with multiple enzymatic functions, including peroxidase activity along with acidic calcium-independent phospholipase A2 (aiPLA2) and lysophosphatidylcholine acyltransferase (LPCAT) activities. Its fundamental physiological functions involve protecting against oxidative stress and maintaining phospholipid homeostasis. Recent studies have shown that Prdx6 is widely involved in the regulation of cellular senescence and influences the development and progression of various age-related diseases. <b><i>Critical Issues:</i></b> Cellular senescence and age-related diseases, due to their complex mechanisms, lack effective treatments. Therefore, there is an urgent need to identify new therapeutic targets. This review discusses the biological characteristics of Prdx6 and its pathophysiological roles in cellular senescence and age-related diseases. Prdx6 may serve as a potential target for modulating cellular senescence and age-related diseases. <b><i>Future Directions:</i></b> The regulatory mechanisms of Prdx6 in age-related diseases warrant further investigation. Additionally, conducting drug screening to identify more molecules that can specifically target Prdx6 will provide new strategies for the treatment of age-related diseases. <i>Antioxid. Redox Signal.</i> 00, 000-000.</p>","PeriodicalId":8011,"journal":{"name":"Antioxidants & redox signaling","volume":" ","pages":""},"PeriodicalIF":5.9000,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases.\",\"authors\":\"Hao Wang, Yingjie Zhao, Fuli Zhou, Fan Chen, Tianyu Chen, Jinhong Wang, Hao Liu, Cheng Sun, Renpeng Zhou, Wei Hu, Chao Lu\",\"doi\":\"10.1089/ars.2024.0793\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Significance:</i></b> Oxidative stress is a key factor in inducing cellular senescence and age-related diseases. When the redox balance within the body is disrupted, sustained oxidative stress can lead to cellular senescence. The accumulation of senescent cells, in turn, triggers a variety of age-related diseases. Peroxiredoxin 6 (Prdx6) is a critical target in the intracellular regulation of redox homeostasis. <b><i>Recent Advances:</i></b> Prdx6 is a widely expressed antioxidant enzyme and the sole member of the peroxiredoxin family endowed with multiple enzymatic functions, including peroxidase activity along with acidic calcium-independent phospholipase A2 (aiPLA2) and lysophosphatidylcholine acyltransferase (LPCAT) activities. Its fundamental physiological functions involve protecting against oxidative stress and maintaining phospholipid homeostasis. Recent studies have shown that Prdx6 is widely involved in the regulation of cellular senescence and influences the development and progression of various age-related diseases. <b><i>Critical Issues:</i></b> Cellular senescence and age-related diseases, due to their complex mechanisms, lack effective treatments. Therefore, there is an urgent need to identify new therapeutic targets. This review discusses the biological characteristics of Prdx6 and its pathophysiological roles in cellular senescence and age-related diseases. Prdx6 may serve as a potential target for modulating cellular senescence and age-related diseases. <b><i>Future Directions:</i></b> The regulatory mechanisms of Prdx6 in age-related diseases warrant further investigation. Additionally, conducting drug screening to identify more molecules that can specifically target Prdx6 will provide new strategies for the treatment of age-related diseases. <i>Antioxid. Redox Signal.</i> 00, 000-000.</p>\",\"PeriodicalId\":8011,\"journal\":{\"name\":\"Antioxidants & redox signaling\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-06-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Antioxidants & redox signaling\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/ars.2024.0793\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antioxidants & redox signaling","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/ars.2024.0793","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases.
Significance: Oxidative stress is a key factor in inducing cellular senescence and age-related diseases. When the redox balance within the body is disrupted, sustained oxidative stress can lead to cellular senescence. The accumulation of senescent cells, in turn, triggers a variety of age-related diseases. Peroxiredoxin 6 (Prdx6) is a critical target in the intracellular regulation of redox homeostasis. Recent Advances: Prdx6 is a widely expressed antioxidant enzyme and the sole member of the peroxiredoxin family endowed with multiple enzymatic functions, including peroxidase activity along with acidic calcium-independent phospholipase A2 (aiPLA2) and lysophosphatidylcholine acyltransferase (LPCAT) activities. Its fundamental physiological functions involve protecting against oxidative stress and maintaining phospholipid homeostasis. Recent studies have shown that Prdx6 is widely involved in the regulation of cellular senescence and influences the development and progression of various age-related diseases. Critical Issues: Cellular senescence and age-related diseases, due to their complex mechanisms, lack effective treatments. Therefore, there is an urgent need to identify new therapeutic targets. This review discusses the biological characteristics of Prdx6 and its pathophysiological roles in cellular senescence and age-related diseases. Prdx6 may serve as a potential target for modulating cellular senescence and age-related diseases. Future Directions: The regulatory mechanisms of Prdx6 in age-related diseases warrant further investigation. Additionally, conducting drug screening to identify more molecules that can specifically target Prdx6 will provide new strategies for the treatment of age-related diseases. Antioxid. Redox Signal. 00, 000-000.
期刊介绍:
Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.
ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.
ARS coverage includes:
-ROS/RNS as messengers
-Gaseous signal transducers
-Hypoxia and tissue oxygenation
-microRNA
-Prokaryotic systems
-Lessons from plant biology